Nano-enabled photosynthesis in tumours to activate lipid peroxidation for overcoming cancer resistances

Jun Jiang1, Weili Wang1, Huizhen Zheng1

  • 1State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Suzhou Medical College, Soochow University, Suzhou, Jiangsu 215123, China.

Biomaterials
|May 10, 2022
PubMed

Insights

This study introduces nano-enabled photosynthesis to induce ferroptosis and overcome melanoma resistance. This novel approach activates nonapoptotic cell death, inhibiting tumor growth and improving survival rates in mice.

Area of Science:

  • Oncology
  • Nanotechnology
  • Biomedical Engineering

Background:

  • Apoptosis dysregulation contributes to intrinsic and acquired melanoma resistance.
  • There is a need for oncological treatments that activate nonapoptotic cell death pathways.

Purpose of the Study:

  • To develop nano-enabled photosynthesis to induce ferroptosis and overcome melanoma resistance.
  • To investigate the efficacy of combining photosynthetic microcapsules (PMCs) with X-rays in treating melanoma.

Main Methods:

  • Photosynthetic microcapsules (PMCs) were engineered by encapsulating cyanobacteria and upconversion nanoparticles in alginate.
  • PMCs were activated by near-infrared photons to create a hyperoxic tumor microenvironment.
  • The combined treatment of PMCs and X-rays was applied to melanoma cells and xenografts.

Main Results:

  • The combination therapy induced lipid peroxidation, Fe2+ release, and ferroptosis in melanoma.
  • This approach effectively suppressed glutathione peroxidase 4 and reduced glutathione levels.
  • The treatment overcame both intrinsic and acquired melanoma resistance, inhibited metastasis, and improved survival rates in mice.

Conclusions:

  • Nano-enabled photosynthesis offers a promising strategy to activate ferroptosis and overcome melanoma resistance.
  • This approach represents a novel avenue for developing advanced oncological treatments.
  • The developed PMCs can be utilized to trigger nonapoptotic cell death pathways in tumors.